ArticleClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association2020

Stopping Mesalamine Therapy in Patients With Crohn's Disease Starting Biologic Therapy Does Not Increase Risk of Adverse Outcomes.

Ryan C Ungaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.